As part of a new deal with the Biomedical Advanced Research and Development Authority, Johnson & Johnson is investing $1bn in COVID-19 vaccine research and development

In a landmark ruling, the big pharma company will pay the state of Oklahoma $572m in damages for its role in fuelling the state’s opioid epidemic